Financing, Equity Capital Markets

Adverum Biotechnologies, Inc.

02/18
|
$69.0 Million
Piper Sandler served as bookrunner for Adverum Biotechnoloties on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma